Jon Nash

893 total citations
18 papers, 654 citations indexed

About

Jon Nash is a scholar working on Experimental and Cognitive Psychology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Jon Nash has authored 18 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Experimental and Cognitive Psychology, 9 papers in Pharmacology and 6 papers in Clinical Psychology. Recurrent topics in Jon Nash's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Treatment of Major Depression (8 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Jon Nash is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Treatment of Major Depression (8 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Jon Nash collaborates with scholars based in United Kingdom, Australia and New Zealand. Jon Nash's co-authors include David Nutt, Spilios V. Argyropoulos, Ann Rich, Caroline Bell, Sean Hood, Jane Hicks, Susan J. Wilson, John Potokar, Carolyn Brice and Andrew Smith and has published in prestigious journals such as NeuroImage, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Jon Nash

18 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon Nash United Kingdom	11	347	209	142	141	125	18	654
Christopher Gross United States	3	256 0.7×	267 1.3×	119 0.8×	294 2.1×	117 0.9×	4	698
Elisa Favaron United Kingdom	11	309 0.9×	252 1.2×	183 1.3×	128 0.9×	119 1.0×	15	674
Gloria Arankowsky‐Sandoval Mexico	18	187 0.5×	312 1.5×	149 1.0×	64 0.5×	207 1.7×	39	748
Tineke Klaassen Netherlands	8	186 0.5×	130 0.6×	142 1.0×	95 0.7×	240 1.9×	9	612
A. Pringle United Kingdom	14	169 0.5×	231 1.1×	104 0.7×	117 0.8×	91 0.7×	21	492
DJ NUTT United Kingdom	9	451 1.3×	354 1.7×	67 0.5×	74 0.5×	97 0.8×	14	769
Kirsten Rohde United States	7	140 0.4×	153 0.7×	104 0.7×	215 1.5×	76 0.6×	9	611
Juha Markkula Finland	12	125 0.4×	211 1.0×	110 0.8×	86 0.6×	103 0.8×	19	513
Mary-Jane Attenburrow United Kingdom	14	141 0.4×	127 0.6×	93 0.7×	88 0.6×	123 1.0×	28	631
S. Argyropoulos United Kingdom	10	465 1.3×	376 1.8×	53 0.4×	78 0.6×	84 0.7×	15	751

Countries citing papers authored by Jon Nash

Since Specialization

Citations

This map shows the geographic impact of Jon Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Nash more than expected).

Fields of papers citing papers by Jon Nash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Nash. The network helps show where Jon Nash may publish in the future.

Co-authorship network of co-authors of Jon Nash

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Nash. A scholar is included among the top collaborators of Jon Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Nash. Jon Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Nash, Jon, et al.. (2017). Trainee experiences of intellectual disability psychiatry and an innovative leaderless support group: A qualitative study. BJPsych Bulletin. 41(4). 228–233. 3 indexed citations

Bell, Caroline, Sean Hood, John Potokar, et al.. (2009). Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder. Psychopharmacology. 213(2-3). 593–602. 7 indexed citations

Nash, Jon, et al.. (2008). Assessment of GABA_ABenzodiazepine Receptor (GBzR) Sensitivity in Patients with Alcohol Dependence. Alcohol and Alcoholism. 43(6). 614–618. 4 indexed citations

Nash, Jon, Peter A. Sargent, Eugenii A. Rabiner, et al.. (2008). Serotonin 5-HT_1A receptor binding in people with panic disorder: positron emission tomography study. The British Journal of Psychiatry. 193(3). 229–234. 131 indexed citations

Nash, Jon & David Nutt. (2007). Psychopharmacology of anxiety. Psychiatry. 6(4). 143–148. 7 indexed citations

Nash, Jon & David Nutt. (2007). Antidepressants. Psychiatry. 6(7). 289–294. 18 indexed citations

Argyropoulos, Spilios V., George B. Ploubidis, Marisha E. Palm, et al.. (2007). Development and validation of the Generalized Anxiety Disorder Inventory (GADI). Journal of Psychopharmacology. 21(2). 145–152. 26 indexed citations

Nash, Jon & David Nutt. (2005). Pharmacotherapy of Anxiety. Handbook of experimental pharmacology. 469–501. 24 indexed citations

Wilson, Sue, Jayne Bailey, Ann Rich, et al.. (2005). The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. Journal of Psychopharmacology. 19(6). 609–613. 25 indexed citations

10.

Argyropoulos, Spilios V., Sean Hood, Caroline Bell, et al.. (2004). Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biological Psychiatry. 56(7). 503–509. 69 indexed citations

11.

Nash, Jon, et al.. (2004). P3.044 Alttered 5HT1A binding in panic disorderdemonstrated by positron emission tomography. European Neuropsychopharmacology. 14. S322–S323. 6 indexed citations

12.

Nash, Jon & David Nutt. (2004). Antidepressants. Psychiatry. 3(7). 22–26. 1 indexed citations

13.

Nash, Jon & David Nutt. (2004). Psychopharmacology of anxiety. Psychiatry. 3(4). 11–15. 13 indexed citations

14.

Argyropoulos, Spilios V., Jane Hicks, Jon Nash, et al.. (2003). Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Research. 120(2). 179–190. 97 indexed citations

15.

Smith, Andrew, et al.. (2003). Caffeine and Central Noradrenaline: Effects on Mood, Cognitive Performance, Eye Movements and Cardiovascular Function. Journal of Psychopharmacology. 17(3). 283–292. 92 indexed citations

16.

Hicks, Jane, Spilios V. Argyropoulos, Ann Rich, et al.. (2002). Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. The British Journal of Psychiatry. 180(6). 528–535. 62 indexed citations

17.

Bell, Caroline, Jon Nash, Sean Hood, et al.. (2002). Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. Journal of Psychopharmacology. 16(1). 5–14. 67 indexed citations

18.

Sargent, Peter A., Jon Nash, Sean Hood, et al.. (2000). 5-HT1A receptor binding in panic disorder; comparison with depressive disorder and healthy volunteers using PET and [11C]WAY-100635. NeuroImage. 11(5). S189–S189. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact